IQCN
gene geneOn this page
Summary
IQCN (IQ motif containing N, HGNC:29350) is a protein-coding gene on chromosome 19p13.11, encoding IQ domain-containing protein N (Q9H0B3). Essential for spermiogenesis and fertilization.
Involved in spermatid development. Located in mitochondrion. Implicated in spermatogenic failure 78.
Source: NCBI Gene 80726 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 327 total — 5 pathogenic, 5 likely-pathogenic
- Phenotypes (HPO): 6
- MANE Select transcript:
NM_001145304
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29350 |
| Approved symbol | IQCN |
| Name | IQ motif containing N |
| Location | 19p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000130518 |
| Ensembl biotype | protein_coding |
| OMIM | 620160 |
| Entrez | 80726 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 retained_intron
ENST00000392413, ENST00000593659, ENST00000595654, ENST00000599528, ENST00000599638, ENST00000600328, ENST00000600359, ENST00000608950, ENST00000865016
RefSeq mRNA: 3 — MANE Select: NM_001145304
NM_001145304, NM_001145305, NM_025249
CCDS: CCDS32958, CCDS46017, CCDS46018
Canonical transcript exons
ENST00000392413 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001399711 | 18264363 | 18267526 |
| ENSE00003044345 | 18257098 | 18258106 |
| ENSE00003465558 | 18269466 | 18269587 |
| ENSE00003842467 | 18274403 | 18274452 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 89.70.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3570 / max 113.1475, expressed in 496 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 179952 | 1.2733 | 487 |
| 179954 | 0.0537 | 6 |
| 179953 | 0.0239 | 4 |
| 179951 | 0.0061 | 3 |
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 89.70 | gold quality |
| left testis | UBERON:0004533 | 88.33 | gold quality |
| right testis | UBERON:0004534 | 88.30 | gold quality |
| testis | UBERON:0000473 | 85.80 | gold quality |
| right uterine tube | UBERON:0001302 | 85.10 | gold quality |
| left uterine tube | UBERON:0001303 | 81.38 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.63 | gold quality |
| mucosa of stomach | UBERON:0001199 | 79.86 | gold quality |
| bone marrow cell | CL:0002092 | 79.09 | gold quality |
| right ovary | UBERON:0002118 | 78.49 | gold quality |
| left ovary | UBERON:0002119 | 78.40 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 77.41 | gold quality |
| body of uterus | UBERON:0009853 | 77.41 | gold quality |
| thyroid gland | UBERON:0002046 | 77.04 | gold quality |
| tibial nerve | UBERON:0001323 | 76.79 | gold quality |
| pituitary gland | UBERON:0000007 | 76.65 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 76.64 | gold quality |
| granulocyte | CL:0000094 | 76.39 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 75.98 | gold quality |
| endocervix | UBERON:0000458 | 75.32 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.20 | gold quality |
| skin of leg | UBERON:0001511 | 74.72 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 74.40 | gold quality |
| ovary | UBERON:0000992 | 73.53 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 73.50 | gold quality |
| skin of abdomen | UBERON:0001416 | 73.46 | gold quality |
| cerebellar cortex | UBERON:0002129 | 73.39 | gold quality |
| popliteal artery | UBERON:0002250 | 73.10 | gold quality |
| tibial artery | UBERON:0007610 | 73.09 | gold quality |
| spleen | UBERON:0002106 | 72.91 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 14.61 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Biallelic variants in IQCN cause sperm flagellar assembly defects and male infertility. (PMID:37140151)
- Loss-of-function mutations in IQCN cause male infertility in humans and mice owing to total fertilization failure. (PMID:37184908)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Iqcn | ENSMUSG00000110622 |
| rattus_norvegicus | Iqcn | ENSRNOG00000068146 |
Paralogs (1): IQCE (ENSG00000106012)
Protein
Protein identifiers
IQ domain-containing protein N — Q9H0B3 (reviewed: Q9H0B3)
All UniProt accessions (5): Q9H0B3, A0A0G2JLK5, U3KQG6, U3KQN7, V9GY12
UniProt curated annotations — full annotation on UniProt →
Function. Essential for spermiogenesis and fertilization. May be required for manchette assembly in elongating spermatids.
Subunit / interactions. Interacts with calmodulin.
Disease relevance. Spermatogenic failure 78 (SPGF78) [MIM:620170] An autosomal recessive, male infertility disorder characterized by a high proportion of sperm head anomalies, primarily tapered and microcephalic heads, and an abnormal acrosome structure. The disease is caused by variants affecting the gene represented in this entry.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H0B3-1 | 1 | yes |
| Q9H0B3-2 | 2 | |
| Q9H0B3-3 | 3 | |
| Q9H0B3-4 | 4 | |
| Q9H0B3-5 | 5 |
RefSeq proteins (3): NP_001138776, NP_001138777, NP_079525 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR052318 | CellDiv_DevSignal_Domain | Family |
Pfam: PF00612
UniProt features (32 total): sequence variant 14, domain 6, splice variant 6, region of interest 4, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H0B3-F1 | 46.56 | 0.13 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, chr19p13, MODULE_49, CTR9_TARGET_GENES, IGLV5_37_TARGET_GENES, MIER1_TARGET_GENES, UBN1_TARGET_GENES, ZNF165_TARGET_GENES, ZNF175_TARGET_GENES, ZNF184_TARGET_GENES, ZNF223_TARGET_GENES, ZNF350_TARGET_GENES, ZNF563_TARGET_GENES
GO Biological Process (1): spermatid development (GO:0007286)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), mitochondrion (GO:0005739)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membrane-bounded organelle | 2 |
| germ cell development | 1 |
| spermatid differentiation | 1 |
| binding | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
1002 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IQCN | C2orf81 | A6NN90 | 606 |
| IQCN | CCDC154 | A6NI56 | 586 |
| IQCN | STMP1 | E0CX11 | 572 |
| IQCN | CFAP184 | Q2M329 | 505 |
| IQCN | GOLGA6L7 | A0A1B0GV03 | 480 |
| IQCN | C20orf173 | Q96LM9 | 471 |
| IQCN | JAKMIP3 | Q5VZ66 | 470 |
| IQCN | HEATR9 | A2RTY3 | 461 |
| IQCN | CABS1 | Q96KC9 | 445 |
| IQCN | TMCO5A | Q8N6Q1 | 437 |
| IQCN | OR5J2 | Q8NH18 | 418 |
| IQCN | SPATA20 | Q8TB22 | 403 |
| IQCN | MYO3B | Q8WXR4 | 402 |
| IQCN | LHFPL7 | Q6ICI0 | 401 |
| IQCN | SPATA31G1 | Q5VYM1 | 400 |
IntAct
38 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TEPSIN | AP4M1 | psi-mi:“MI:0914”(association) | 0.700 |
| CALML3 | IQCN | psi-mi:“MI:0915”(physical association) | 0.670 |
| IQCN | CALM1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| LZTS2 | IQCN | psi-mi:“MI:0915”(physical association) | 0.670 |
| IQCN | CALML3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| CALM1 | IQCN | psi-mi:“MI:0915”(physical association) | 0.670 |
| IQCN | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HEL-S-72 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| RBM17 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | HEL-S-72 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM27 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | SIAH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | PUF60 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | TRIM27 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SIAH1 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| PUF60 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| MID2 | IQCN | psi-mi:“MI:0915”(physical association) | 0.560 |
| IQCN | RBM17 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (119): KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), LZTS2 (Two-hybrid), RBM17 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid), KIAA1683 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTH6, A0A1B0GUW6, A0A1D5RMD1, A2AQH4, A4FU49, A6NJ88, C4P6S0, D3YU32, E9PAV3, F1QU13, I3L273, J3KML8, P70670, Q32L62, Q3V0E1, Q3V3Q4, Q4R729, Q5H9F3, Q5QJ38, Q5SWP3, Q5U4C1, Q5VWK0, Q5VYM1, Q68DN1, Q6AZ54, Q7TSG5, Q810T2, Q8CH19, Q8K4E0, Q8N3K9, Q8N5Q1, Q8NDH2, Q8TCU4, Q8WNU4, Q8WWL7, Q920R4, Q921B4, Q923B3, Q96JA4, Q96M34
Diamond homologs: A0A1D5RMD1, Q8WNU4, Q9H0B3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
327 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 5 |
| Likely pathogenic | 5 |
| Uncertain significance | 249 |
| Likely benign | 54 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (10)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3774324 | IQCN, THR1305SER | Pathogenic |
| 3774325 | IQCN, SER1003PHE | Pathogenic |
| 3774326 | IQCN, R1125HIS | Pathogenic |
| 3774327 | I1014V | Pathogenic |
| 3774328 | NM_001145304.2(IQCN):c.1061_1062del (p.Tyr354fs) | Pathogenic |
| 2626860 | NM_001145304.2(IQCN):c.910C>T (p.Gln304Ter) | Likely pathogenic |
| 4845724 | NM_001145304.2(IQCN):c.2547G>A (p.Trp849Ter) | Likely pathogenic |
| 4845830 | NM_001145304.2(IQCN):c.3004C>T (p.Gln1002Ter) | Likely pathogenic |
| 4849442 | NM_001145304.2(IQCN):c.1523dup (p.Leu508fs) | Likely pathogenic |
| 4849466 | NM_001145304.2(IQCN):c.2453del (p.Gln818fs) | Likely pathogenic |
SpliceAI
653 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:18269594:C:CT | acceptor_gain | 0.9900 |
| 19:18269595:A:T | acceptor_gain | 0.9900 |
| 19:18269600:C:CT | acceptor_gain | 0.9900 |
| 19:18269601:A:T | acceptor_gain | 0.9900 |
| 19:18269460:TCTTA:T | donor_loss | 0.9800 |
| 19:18269461:CTTAC:C | donor_loss | 0.9800 |
| 19:18269462:TTAC:T | donor_loss | 0.9800 |
| 19:18269463:TACCT:T | donor_loss | 0.9800 |
| 19:18269464:ACC:A | donor_loss | 0.9800 |
| 19:18269465:CCTTG:C | donor_loss | 0.9800 |
| 19:18269603:C:CT | acceptor_gain | 0.9800 |
| 19:18274399:TCACC:T | donor_loss | 0.9800 |
| 19:18274400:CA:C | donor_loss | 0.9800 |
| 19:18274402:CCT:C | donor_loss | 0.9800 |
| 19:18274424:G:C | donor_gain | 0.9600 |
| 19:18269588:C:CC | acceptor_gain | 0.9500 |
| 19:18269600:C:T | acceptor_gain | 0.9500 |
| 19:18274401:ACCTG:A | donor_gain | 0.9500 |
| 19:18274402:CCTGC:C | donor_gain | 0.9500 |
| 19:18269584:TGGG:T | acceptor_gain | 0.9400 |
| 19:18269586:GG:G | acceptor_gain | 0.9400 |
| 19:18274401:A:AC | donor_gain | 0.9400 |
| 19:18274402:C:CC | donor_gain | 0.9400 |
| 19:18269585:GGGC:G | acceptor_gain | 0.9300 |
| 19:18274402:CCTG:C | donor_gain | 0.9200 |
| 19:18269605:C:CT | acceptor_gain | 0.9100 |
| 19:18267523:CTGC:C | acceptor_gain | 0.9000 |
| 19:18270727:A:AC | donor_gain | 0.9000 |
| 19:18270728:C:CC | donor_gain | 0.9000 |
| 19:18264090:T:TA | donor_gain | 0.8800 |
AlphaMissense
8778 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:18267021:G:C | F173L | 0.987 |
| 19:18267021:G:T | F173L | 0.987 |
| 19:18267023:A:G | F173L | 0.987 |
| 19:18267267:G:C | F91L | 0.986 |
| 19:18267267:G:T | F91L | 0.986 |
| 19:18267269:A:G | F91L | 0.986 |
| 19:18257290:C:G | A1145P | 0.980 |
| 19:18257920:C:G | A935P | 0.975 |
| 19:18267276:G:C | S88R | 0.975 |
| 19:18267276:G:T | S88R | 0.975 |
| 19:18267278:T:G | S88R | 0.975 |
| 19:18257851:C:G | A958P | 0.974 |
| 19:18257621:G:C | F1034L | 0.973 |
| 19:18257621:G:T | F1034L | 0.973 |
| 19:18257623:A:G | F1034L | 0.973 |
| 19:18267211:A:G | I110T | 0.970 |
| 19:18267206:C:G | A112P | 0.969 |
| 19:18257295:A:T | V1143D | 0.966 |
| 19:18267268:A:G | F91S | 0.963 |
| 19:18267120:G:C | F140L | 0.961 |
| 19:18267120:G:T | F140L | 0.961 |
| 19:18267122:A:G | F140L | 0.961 |
| 19:18267221:C:G | A107P | 0.960 |
| 19:18257353:A:G | W1124R | 0.959 |
| 19:18257353:A:T | W1124R | 0.959 |
| 19:18267131:A:G | W137R | 0.958 |
| 19:18267131:A:T | W137R | 0.958 |
| 19:18257280:C:G | R1148P | 0.957 |
| 19:18257518:A:G | C1069R | 0.957 |
| 19:18257845:A:G | W960R | 0.956 |
dbSNP variants (sampled 300 via entrez): RS1000128963 (19:18266342 T>C), RS1000253499 (19:18275362 T>C), RS1000717083 (19:18268683 G>A,T), RS1000940649 (19:18260160 A>C,G), RS1001194309 (19:18274126 T>C), RS1001320916 (19:18275112 T>A), RS1001391933 (19:18269751 G>T), RS1001546808 (19:18274549 G>A), RS1001588228 (19:18268224 A>G), RS1001766000 (19:18274337 CCA>C), RS1001872175 (19:18270152 G>C), RS1001966084 (19:18258221 A>C), RS1002452093 (19:18259566 G>A), RS1002560238 (19:18260496 C>T), RS1002575833 (19:18263831 C>T)
Disease associations
OMIM: gene MIM:620160 | disease phenotypes: MIM:620170
GenCC curated gene-disease
Mondo (1): spermatogenic failure 78 (MONDO:0859338)
Orphanet (0):
HPO phenotypes
6 total (6 of 6 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0032561 | Microcephalic sperm head |
| HP:0032562 | Tapered sperm head |
| HP:0033712 | Repeated implantation failure |
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007876_77 | Estimated glomerular filtration rate | 2.000000e-10 |
| GCST007932_3 | Medication use (thyroid preparations) | 9.000000e-15 |
| GCST90016671_4 | Visceral adipose tissue volume | 4.000000e-08 |
| GCST90020024_534 | A body shape index | 4.000000e-11 |
| GCST90020025_1431 | Waist-to-hip ratio adjusted for BMI | 4.000000e-23 |
| GCST90020027_273 | Waist-hip index | 4.000000e-23 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009933 | Thyroid preparation use measurement |
| EFO:0007789 | BMI-adjusted waist circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects binding, increases reaction, decreases expression, increases expression | 3 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases expression, increases methylation | 3 |
| (+)-JQ1 compound | increases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| sotorasib | increases expression, affects cotreatment | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionic acid | increases expression | 1 |
| 15-acetyldeoxynivalenol | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| trametinib | affects cotreatment, increases expression | 1 |
| NVP-BKM120 | affects cotreatment, increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Dronabinol | increases expression | 1 |
| Thiram | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Triclosan | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 78